Lifecore Biomedical Share Price (NASDAQ: LFCR)

$7.62

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Lifecore Biomedical Stock chart to analyse performance

Lifecore Biomedical stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$7.58
Today's High:$7.62
$7.62
0.52%
Downside
Day's Volatility :0.52%
Upside
0.0%
52 Weeks Low:$3.89
52 Weeks High:$8.85
$7.62
48.95%
Downside
52 Weeks Volatility :56.05%
Upside
13.9%

Lifecore Biomedical Stock Returns

Period	Lifecore Biomedical Inc	Index (Russel 2000)
3 Months	11.06%	0.0%
6 Months	33.39%	0.0%
1 Year	74.6%	0.0%
3 Years	-25.49%	-4.7%

Lifecore Biomedical Inc Key Stats

Check Lifecore Biomedical key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$7.62
Open	$7.57
Today's High	$7.62
Today's Low	$7.58
Market Capitalization	$285.0M
Today's Volume	$68.0K
52 Week High	$8.85
52 Week Low	$3.89
Revenue TTM	$128.9M
EBITDA	$-4.0M
Earnings Per Share (EPS)	$-1.29
Profit Margin	-30.04%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-76.41%

Stock Returns calculator for Lifecore Biomedical Stock including INR - Dollar returns

The Lifecore Biomedical stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Lifecore Biomedical investment value today

Current value as on today

₹1,79,257

Returns

₹79,257

(+79.26%)

Returns from Lifecore Biomedical Stock

₹73,973 (+73.97%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Lifecore Biomedical Stock

33%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Lifecore Biomedical Stock from India on INDmoney has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Lifecore Biomedical Inc

Name
Holdings %
Name
Holdings %
Wynnefield Capital Inc
12.57%
Legion Partners Asset Management, LLC
11.85%
Greenhaven Road Investment Management, L.P.
9.88%
325 Capital LLC
5.78%
BlackRock Inc
4.72%
22NW, LP
4.69%

Analyst Recommendation on Lifecore Biomedical Stock

Rating

Trend

Sell

0%Buy

50%Hold

50%Sell

Based on 6 Wall street analysts offering stock ratings for Lifecore Biomedical(by analysts ranked 0 to 5 stars)

Lifecore Biomedical Share Price Target

What analysts predicted

Upside of 31.23%

Target:

$10.00

Current:

$7.62

Lifecore Biomedical share price target is $10.00, a slight Upside of 31.23% compared to current price of $7.62 as per analysts' prediction.

Lifecore Biomedical Stock Insights

Price Movement
In the last 1 year, LFCR stock has moved up by 74.2%
Increasing Revenue
Revenue is up for the last 4 quarters, 24.70M → 36.44M (in $), with an average increase of 11.7% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -14.76M → -1.14M (in $), with an average increase of 1187.6% per quarter
LFCR vs HLN (3 yr)
In the last 3 years, Haleon Plc Spon Ads has given 35.1% return, outperforming this stock by 59.9%

Lifecore Biomedical Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Revenue	$590.4M	↑ 5.88%
Net Income	$-38.2M	↓ 1899.76%
Net Profit Margin	-6.47%	↓ 6.85%

	FY21	Y/Y Change
Revenue	$100.9M	↓ 82.91%
Net Income	$-32.7M	↓ 14.47%
Net Profit Margin	-32.38%	↓ 25.91%

	FY22	Y/Y Change
Revenue	$185.8M	↑ 84.18%
Net Income	$-97.4M	↑ 198.27%
Net Profit Margin	-52.44%	↓ 20.06%

	FY23	Y/Y Change
Revenue	$111.3M	↓ 40.11%
Net Income	$-116.7M	↑ 19.79%
Net Profit Margin	-104.89%	↓ 52.45%

	FY24	Y/Y Change
Revenue	$128.3M	↑ 15.27%
Net Income	$12.0M	↓ 110.29%
Net Profit Margin	9.37%	↑ 114.26%

	FY25	Y/Y Change
Revenue	$128.9M	↑ 0.47%
Net Income	$-38.7M	↓ 422.29%
Net Profit Margin	-30.04%	↓ 39.41%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$31.5M	↑ 4.63%
Net Income	$-36.1M	↓ 354.11%
Net Profit Margin	-114.53%	↓ 161.69%

	Q2 FY24	Q/Q Change
Revenue	$37.9M	↑ 20.1%
Net Income	$-7.1M	↓ 80.4%
Net Profit Margin	-18.7%	↑ 95.83%

	Q3 FY24	Q/Q Change
Revenue	$24.7M	↓ 34.79%
Net Income	$-16.2M	↑ 129.14%
Net Profit Margin	-65.7%	↓ 47.0%

	Q4 FY24	Q/Q Change
Revenue	$32.6M	↑ 31.81%
Net Income	$-6.6M	↓ 59.51%
Net Profit Margin	-20.18%	↑ 45.52%

	Q1 FY25	Q/Q Change
Revenue	$35.2M	↑ 7.95%
Net Income	$-14.8M	↑ 124.76%
Net Profit Margin	-42.01%	↓ 21.83%

	Q2 FY25	Q/Q Change
Revenue	$36.4M	↑ 3.67%
Net Income	$-1.1M	↓ 92.23%
Net Profit Margin	-3.15%	↑ 38.86%

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Profit	$75.0M	↓ 7.43%

	FY21	Y/Y Change
Profit	$38.9M	↓ 48.08%

	FY22	Y/Y Change
Profit	$50.4M	↑ 29.36%

	FY23	Y/Y Change
Profit	$39.1M	↓ 22.44%

	FY24	Y/Y Change
Profit	$41.9M	↑ 7.13%

	FY25	Y/Y Change
Profit	$40.3M	↓ 3.71%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$8.4M	↓ 15.73%

	Q2 FY24	Q/Q Change
Profit	$17.3M	↑ 105.84%

	Q3 FY24	Q/Q Change
Profit	$5.4M	↓ 68.81%

	Q4 FY24	Q/Q Change
Profit	$11.1M	↑ 105.75%

	Q1 FY25	Q/Q Change
Profit	$9.8M	↓ 11.18%

	Q2 FY25	Q/Q Change
Profit	$14.0M	↑ 42.02%

FY20

FY21

FY22

FY23

FY24

FY25

	FY20	Y/Y Change
Operating Cash Flow	$-17.0M	↓ 206.37%
Investing Cash Flow	$-23.9M	↓ 75.32%
Financing Cash Flow	$40.0M	↓ 49.36%

	FY21	Y/Y Change
Operating Cash Flow	$16.5M	↓ 196.66%
Investing Cash Flow	$-12.3M	↓ 48.47%
Financing Cash Flow	$-3.4M	↓ 108.54%

	FY22	Y/Y Change
Operating Cash Flow	$-24.4M	↓ 248.13%
Investing Cash Flow	$81.8M	↓ 764.24%
Financing Cash Flow	$-57.0M	↑ 1567.77%

	FY23	Y/Y Change
Operating Cash Flow	$-24.4M	↑ 0.0%
Investing Cash Flow	$81.8M	↑ 0.0%
Financing Cash Flow	$-57.0M	↑ 0.0%

	FY24	Y/Y Change
Operating Cash Flow	$-217.0K	↓ 99.11%
Investing Cash Flow	$-17.9M	↓ 121.92%
Financing Cash Flow	$7.5M	↓ 113.17%

	FY25	Y/Y Change
Operating Cash Flow	$-206.0K	↓ 5.07%
Investing Cash Flow	$-6.4M	↓ 64.2%
Financing Cash Flow	$6.4M	↓ 14.45%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$-17.3M	↓ 1442.31%
Investing Cash Flow	$-7.5M	-
Financing Cash Flow	$20.9M	↓ 953.84%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$8.6M	↓ 149.97%
Investing Cash Flow	$-2.6M	↓ 64.84%
Financing Cash Flow	$-738.0K	↓ 103.53%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$-643.0K	↓ 107.44%
Investing Cash Flow	$-3.4M	↑ 28.63%
Financing Cash Flow	$1.1M	↓ 248.1%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-6.1M	↑ 850.23%
Investing Cash Flow	$-2.5M	↓ 27.18%
Financing Cash Flow	$12.5M	↑ 1045.01%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$1.2M	↓ 119.64%
Investing Cash Flow	$1.5M	↓ 162.51%
Financing Cash Flow	$-6.8M	↓ 154.19%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$5.3M	↑ 345.58%
Investing Cash Flow	$-2.1M	↓ 235.82%
Financing Cash Flow	$-402.0K	↓ 94.07%

Lifecore Biomedical Technicals Summary

Sell

Neutral

Buy

Lifecore Biomedical is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Lifecore Biomedical Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Lifecore Biomedical Inc	9.0%	33.39%	74.6%	-25.49%	-26.71%
Haleon Plc Spon Ads	1.5%	-7.33%	-3.49%	69.05%	32.32%
United Therapeutics Corporation	3.57%	-1.69%	-13.51%	34.83%	71.41%
Zoetis Inc.	6.13%	-8.28%	-14.8%	-1.88%	-3.48%
Neurocrine Biosciences Inc.	8.29%	21.94%	11.59%	32.16%	20.59%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Lifecore Biomedical Inc	57.15	NA	3.51	-1.33	-0.76	-0.03	NA	0.04
Haleon Plc Spon Ads	21.53	21.53	3.14	0.49	0.09	0.05	0.01	1.77
United Therapeutics Corporation	11.9	11.9	1.43	26.59	0.19	0.13	NA	158.65
Zoetis Inc.	26.97	26.97	2.53	6.33	0.53	0.15	0.01	11.21
Neurocrine Biosciences Inc.	41.3	41.3	0.27	6.74	0.13	0.09	NA	27.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Lifecore Biomedical Inc	Sell	$285.0M	-26.71%	57.15	-30.04%
Haleon Plc Spon Ads	Buy	$43.4B	32.32%	21.53	13.81%
United Therapeutics Corporation	Buy	$13.8B	71.41%	11.9	40.36%
Zoetis Inc.	Buy	$69.3B	-3.48%	26.97	27.83%
Neurocrine Biosciences Inc.	Buy	$13.8B	20.59%	41.3	13.88%

About Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of hyaluronate acid (HA) in bulk form, as well as formulated and filled syringes, cartridges, and vials for injectable products used in treating a range of medical conditions and procedures. Its product development services include analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and production of materials for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.

Organization	Lifecore Biomedical
Employees	406
CEO	Mr. Paul Josephs
Industry	Healthcare

Key Management of Lifecore Biomedical Inc

Name	Title
Mr. Paul Josephs	President, CEO & Director
Mr. Ryan D. Lake CPA	Executive VP & CFO
Mr. Thomas Guldager	Senior Vice President of Operations
Mr. Thomas Salus	Chief Legal & Administration Officer and Corporate Secretary
Mr. Aaron Perlitsh	Director of Internal Audit & Chief Compliance Officer
Ms. Jackie Q. Klecker	Executive Vice President of Quality & Development Services
Mr. Mark DaFonseca	Chief Commercial Officer
Mr. Parker K. Javid	Vice President

Important FAQs about investing in LFCR Stock from India :

What is Lifecore Biomedical share price today?

Lifecore Biomedical share price today is $7.62 as on August 30, 2025 at 1:29 am IST at the close of the market. Lifecore Biomedical share today touched a day high of $7.62 and a low of $7.58.

What is the 52 week high and 52 week low for Lifecore Biomedical share?

Lifecore Biomedical share touched a 52 week high of $8.85 and a 52 week low of $3.89. Lifecore Biomedical stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $7.62, lower by 13.9% versus the 52 week high.

How to invest in Lifecore Biomedical Stock (LFCR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Lifecore Biomedical on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Lifecore Biomedical Shares that will get you 0.1969 shares as per Lifecore Biomedical share price of $7.62 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Lifecore Biomedical Stock (LFCR) from India?

Indian investors can start investing in Lifecore Biomedical (LFCR) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Lifecore Biomedical stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Lifecore Biomedical share’s latest price of $7.62 as on August 30, 2025 at 1:29 am IST, you will get 1.3123 shares of Lifecore Biomedical. Learn more about fractional shares .

What are the returns that Lifecore Biomedical has given to Indian investors in the last 5 years?

Lifecore Biomedical stock has given -26.71% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?